The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al
- PMID: 21452333
- DOI: 10.1002/art.30226
The rarity of antinuclear antibody negativity in systemic lupus erythematosus: comment on the article by Merrill et al
Comment on
-
The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial.Arthritis Rheum. 2010 Oct;62(10):3077-87. doi: 10.1002/art.27601. Arthritis Rheum. 2010. PMID: 20533545 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical